
Probus Pharmaceuticals Private Limited
Founded in 2017 and headquartered in Jharkhand, India.
Founded in 2017 and headquartered in Jharkhand, India.
Seraikela-Kharsawan, Jharkhand, India
+91-XXXXXXXXXX
U24304JH2017PTC009452
009452
Private Limited Indian Non-Government Company
17 Jan 2017
-
-
Unlisted
Roc Jharkhand
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rani Kumari ![]() | Director | 17-Jan-2017 | Current |
Preeti Jha ![]() | Director | 17-Jan-2017 | Current |
Ashish Jha ![]() | Director | 17-Jan-2017 | Current |
Enhance accessibility to Probus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Probus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Rani Kumari, Preeti Jha and 1 more are mutual person
Rani Kumari and Preeti Jha are mutual person
Preeti Jha and Ashish Jha are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Probus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Probus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Probus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rani Kumari was appointed as a Director was appointed as a Director on 17 Jan 2017 & has been associated with this company since 8 years 2 months .
Preeti Jha was appointed as a Director was appointed as a Director on 17 Jan 2017 & has been associated with this company since 8 years 2 months .
Ashish Kumar Jha was appointed as a Director was appointed as a Director on 17 Jan 2017 & has been associated with this company since 8 years 2 months .
Probus Pharmaceuticals Private Limited was registered on 17 Jan 2017 with Roc Jharkhand & aged 8 years 2 months as per MCA records.
Probus Pharmaceuticals Private Limited was incorporated on 17 Jan 2017.
The authorized share capital of Probus Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Probus Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Probus Pharmaceuticals Private Limited is Bagebera Housing Colony Roadno-06, Near R.P. Patel High School Jamshedpur Jugsalai, East SinghbhumJamshedpur Purba Singhbhum, Jharkhand, India, 831002.
The corporate identification number (CIN) of Probus Pharmaceuticals Private Limited is U24304JH2017PTC009452 and the company number is 009452 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.
HM